Immunovant (IMVT) Stock: Buy, Sell, or Hold?
IMVT - Immunovant, Inc. Common Stock
$28.38
-0.21 (-0.73%)
▼
5d:
+1.72%
30d:
-23.89%
90d:
-27.91%
HOLD
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 09, 2026
17d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Oct 21, 2026 at $28.31 · last confirmed Oct 21, 2026
Strength: 8.1/10
Get Alerted When IMVT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IMVT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IMVT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IMVT is currently trading at $28.38, which is considered oversold relative to its 30-day fair value range of $29.15 to $36.04.
Technical Outlook: Technically, IMVT is in a downtrend. Immediate support is located at $26.27, while resistance sits at $31.50.
Market Sentiment: IMVT scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $48.88 (+72.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IMVT is in a downtrend. Immediate support is located at $26.27, while resistance sits at $31.50.
Market Sentiment: IMVT scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $48.88 (+72.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$29.15 -
$36.04
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
Protect Your Profits
Holding IMVT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 72.2% below Wall St target ($48.88)
- CAUTION: Bottoming setup, but lagging the sector by 10% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$29.15 -
$36.04
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$26.28
Resistance Level
$31.50
Current Trend
Downtrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.99
Wall Street Target
$48.88
(+72.2%)
Share & Embed Analysis
Last updated: October 22, 2026 7:44 AM ET
Data refreshes hourly during market hours. Next update: 8:44 AM
Data refreshes hourly during market hours. Next update: 8:44 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMVT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$295 | 56 HOLD |
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$864 | 47 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 71 BUY |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
20 analysts |
$650 | 50 HOLD |
|
ELVN
Enliven Therapeutics Inc. |
STRONG BUY
14 analysts |
$74 | 63 BUY |
Advanced IMVT Option Strategies
Professional options setups generated by AI based on today's IMVT price and gamma walls.
